The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The proposed facility is expected to be operational around January, 2027
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
Additional capacity broadens Grace’s fine chemical capabilities for API production
NEIAFMR to be developed as the national hub for folk medicine
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Subscribe To Our Newsletter & Stay Updated
